Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORTIN LABS vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORTIN LABS ASTRAZENECA PHARMA ORTIN LABS /
ASTRAZENECA PHARMA
 
P/E (TTM) x -2.0 193.7 - View Chart
P/BV x 5.4 22.4 24.0% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ORTIN LABS    ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ORTIN LABS
Mar-24
ASTRAZENECA PHARMA
Mar-24
ORTIN LABS /
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs307,208 0.4%   
Low Rs163,102 0.5%   
Sales per share (Unadj.) Rs2.6518.2 0.5%  
Earnings per share (Unadj.) Rs-9.964.6 -15.3%  
Cash flow per share (Unadj.) Rs-9.670.6 -13.6%  
Dividends per share (Unadj.) Rs024.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs3.5283.5 1.2%  
Shares outstanding (eoy) m8.1325.00 32.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.99.9 90.0%   
Avg P/E ratio x-2.479.8 -2.9%  
P/CF ratio (eoy) x-2.473.0 -3.3%  
Price / Book Value ratio x6.718.2 36.8%  
Dividend payout %037.1 -0.0%   
Avg Mkt Cap Rs m189128,875 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m52,415 0.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2112,955 0.2%  
Other income Rs m2348 0.5%   
Total revenues Rs m2313,303 0.2%   
Gross profit Rs m-652,009 -3.3%  
Depreciation Rs m2149 1.5%   
Interest Rs m512 40.2%   
Profit before tax Rs m-712,195 -3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10580 1.7%   
Profit after tax Rs m-801,615 -5.0%  
Gross profit margin %-309.615.5 -1,996.5%  
Effective tax rate %-13.726.4 -51.6%   
Net profit margin %-380.712.5 -3,054.0%  
BALANCE SHEET DATA
Current assets Rs m7510,427 0.7%   
Current liabilities Rs m324,672 0.7%   
Net working cap to sales %203.944.4 459.0%  
Current ratio x2.42.2 105.9%  
Inventory Days Days4047 85.7%  
Debtors Days Days3,05343 7,076.3%  
Net fixed assets Rs m22,342 0.1%   
Share capital Rs m8150 162.6%   
"Free" reserves Rs m-537,036 -0.8%   
Net worth Rs m287,086 0.4%   
Long term debt Rs m180-   
Total assets Rs m7712,769 0.6%  
Interest coverage x-13.7184.0 -7.4%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.31.0 27.0%   
Return on assets %-98.112.7 -769.5%  
Return on equity %-284.722.8 -1,249.3%  
Return on capital %-142.531.2 -457.5%  
Exports to sales %00-   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA61 0.0%   
Fx inflow Rs m01,094 0.0%   
Fx outflow Rs m061 0.0%   
Net fx Rs m01,033 0.0%   
CASH FLOW
From Operations Rs m-48279 -17.2%  
From Investments Rs m120217 55.2%  
From Financial Activity Rs m-35-444 7.9%  
Net Cashflow Rs m3752 71.2%  

Share Holding

Indian Promoters % 1.2 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 6.3 8.0 78.1%  
FIIs % 6.3 2.9 215.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 98.8 25.0 395.1%  
Shareholders   12,165 27,615 44.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORTIN LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on ORTIN LABS vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ORTIN LABS vs ASTRAZENECA PHARMA Share Price Performance

Period ORTIN LABS ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day -3.06% 0.16% 0.86%
1-Month 0.05% -11.10% 1.18%
1-Year -7.11% 33.63% 46.15%
3-Year CAGR -12.58% 27.83% 19.61%
5-Year CAGR 16.13% 18.33% 26.10%

* Compound Annual Growth Rate

Here are more details on the ORTIN LABS share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of ORTIN LABS hold a 1.2% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ORTIN LABS and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, ORTIN LABS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

ASTRAZENECA PHARMA paid Rs 24.0, and its dividend payout ratio stood at 37.1%.

You may visit here to review the dividend history of ORTIN LABS , and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq(Pre-Open)

Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.